Calcitonin. A review of experimental and clinical investigations

降钙素:实验和临床研究综述

阅读:1

Abstract

In 1962 Copp proposed the existence of a hypocalcaemic hormone. Subsequent studies have shown him to be right. Calcitonin is a potent inhibitor of bone resorption. By its action it lowers systemic blood calcium. It is secreted in response to hypercalcaemia by a distinct endocrine system within the thyroid in mammals and within the ultimobranchial bodies in fish, amphibia and reptiles. The active principle from pig has now been isolated and found to be a polypeptide composed of thirty-two amino acid residues. Together with parathyroid hormone, the hormone provides precise regulation of calcium concentration in the blood and controls bone remodelling and mineral turnover. Calcitonin in man may be secreted in excessive amounts by medullary carcinoma of the thyroid. In addition, aberrations in its secretion may play a role in pseudohyper-parathyroidism and ostepetrosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。